Medi-first Ibuprofen Tablet, Film Coated
Product Images NDC 47682-608

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Medi-first Ibuprofen (NDC 47682-608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unifirst First Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100r Dover Addaprin 1625314 Rev 5 1 22 Label 2

100r Dover Addaprin 1625314 Rev 5 1 22 Label 2
This is a package of Ibuprofen 200 mg Tablets that contains 500 tablets in 250 packets of 2 each. It is a non-steroidal anti-inflammatory drug (NSAID) used for pain relief and reducing fever. The package contains tamper-evident sealed packets. It is manufactured by Medique Products, based in Fort Myers, Florida. The text also contains information related to pharmaceutical products, blood pressure regulation, and business regulations.*
FDA Label Image

100r Iprin 10047 Rev 5 1 22 Label

FDA Label Image

100r Mf Ibuprofen 80833 Rev 5 1 22 Label

100r Mf Ibuprofen 80833 Rev 5 1 22 Label
MEDI-FIRST is a Pain Reliever/Fever Reducer product in a tamper-evident unit dose package that contains Ibuprofen (NSAID) 200mg to temporarily relieve minor aches and pains associated with menstrual cramps, headache, toothache, muscular aches, backache, and common cold, among others. The medication may cause severe allergic reactions, including hives, swelling, asthma, shock, or blisters. The package comes with a stomach bleeding warning; it contains NSAID, which may cause severe stomach bleeding. The medicine is not advisable if you have a history of stomach problems or bleeding problems, taking other medicines containing prescription or non-prescription NSAIDs, or if you have three or more alcoholic drinks every day while using the product. Other important information before using the product includes asking the doctor or pharmacist if under a doctor's care for any serious condition or taking any other drug. It is a pregnant woman's precaution and is not to be used if at 20 weeks or later of pregnancy, unless directed by a doctor. The product should be kept out of reach of children and must be initially taken with food or milk if stomach upset occurs. If symptoms persist last longer than ten days, worsen, or appear unexpectedly, seek medical help immediately.*
FDA Label Image

100r Mfp Ibuprofen 90833 Rev 5 1 22 Label

100r Mfp Ibuprofen 90833 Rev 5 1 22 Label
This is a drug information sheet for Ibuprofen 200mg. It is a pain reliever that is to be used according to packaging directions. The sheet features information such as dosage instructions, warnings, active and inactive ingredients, and contact information for questions or comments. The packaging is not recommended for households with young children. This -generated text also contains several typos that may need to be corrected.*
FDA Label Image

Otis Clapp Ultraprin Label 1 31 19

Otis Clapp Ultraprin Label 1 31 19
ULTRAPRIN® is a pain reliever and fever reducer (NSAID) containing Ibuprofen Tablets USP 200mg that will not cause drowsiness. It fights headaches, reduces inflammation, and relieves body aches. It is intended for deep-seated pain and should be taken as directed in the warnings and directions on the side panel. Stomach soothing and weight gain may occur, and individuals with questions should consult a healthcare professional. The carton should be retained for complete product information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.